GS
PILL icon

GTS Securities’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

GTS Securities’s Portfolio PILL Stock Details PILL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,675
Closed -$385K – 1691
2025
Q3 		$385K Buy
47,675
+37,163
+354% +$252K 0.01% 886
2025
Q2 		$54.3K Buy
+10,512
New +$54.5K ﹤0.01% 1175

Other funds holding PILL

Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities's PILL Position: Q4 2025 in Review

GTS Securities sold out of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) in Q4 2025, closing a stake of 47,675 shares — an estimated $385K sold.

GTS Securities first reported a position in PILL in Q2 2025 and held it in 2 quarters. The position peaked at $385K in Q3 2025. 4 funds tracked by Wall St. Rank hold PILL as of Q4 2025.

  • GTS Securities reported no remaining Direxion Daily Pharmaceutical & Medical Bull 3X ETF position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 47,675 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q4 2025, an estimated $385K.
  • GTS Securities first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q2 2025 and held it in 2 quarters.
  • GTS Securities's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $385K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.